Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Dasiglucagon clinical trials
10 selected ClinicalTrials.gov records carrying the official matched intervention Dasiglucagon (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
10 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 2 selected PubMed records and 1 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT03378635
PeptideScanner retained ClinicalTrials.gov record NCT03378635 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was dasiglucagon.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 10, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03688711
PeptideScanner retained ClinicalTrials.gov record NCT03688711 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-05-19, and PeptideScanner's reviewed identity mapping was dasiglucagon.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 19, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03735225
PeptideScanner retained ClinicalTrials.gov record NCT03735225 at 2026-11-16T01:42:39.027Z. Its registry update date was 2021-03-23, and PeptideScanner's reviewed identity mapping was dasiglucagon.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- March 23, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Dasiglucagon · 2025-07-20
ClinicalTrials.gov record NCT05378672
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2023-12-13
ClinicalTrials.gov record NCT03777176
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2023-02-02
ClinicalTrials.gov record NCT04836273
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2022-09-07
ClinicalTrials.gov record NCT04764968
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2021-06-10
ClinicalTrials.gov record NCT03378635
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2021-05-19
ClinicalTrials.gov record NCT03688711
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2021-03-23
ClinicalTrials.gov record NCT03735225
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2021-02-09
ClinicalTrials.gov record NCT04449692
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2020-03-31
ClinicalTrials.gov record NCT03984370
Completed at the retained observation.
Open attributed record →Dasiglucagon · 2019-12-16
ClinicalTrials.gov record NCT03840278
Completed at the retained observation.
Open attributed record →